8-K: GRI Bio, Inc. Changes Independent Registered Public Accounting Firm

GRI Bio, Inc. announces the dismissal of Sadler Gibb & Associates LLC and the appointment of WithumSmith+Brown, PC as its new independent registered public accounting firm.

Summary

• On April 11, 2025, GRI Bio, Inc.'s Audit Committee approved the dismissal of Sadler Gibb & Associates LLC as the company's independent registered public accounting firm.
• The dismissal was not due to any disagreements regarding accounting principles, financial statement disclosure, or auditing scope.
• Sadler's reports for the fiscal years ended December 31, 2024 and 2023 did not contain adverse opinions or disclaimers, except for an explanatory paragraph about the company's ability to continue as a going concern.
• There were no disagreements or reportable events between GRI Bio and Sadler, except for previously reported material weaknesses in internal control over financial reporting related to the accounting of pre-pricing of certain warrants.
• The company implemented a plan to remediate the material weakness, and no restatements of prior periods were required.
• On April 11, 2025, the Audit Committee appointed WithumSmith+Brown, PC as the company's new independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The company did not consult with Withum regarding any matters described in Items 304(a)(2)(i) and (ii) of Regulation S-K during the two most recent fiscal years and the interim period through April 11, 2025.
• Sadler provided a letter to the SEC agreeing with the company's statements regarding their dismissal.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While there's a change in auditors and a previously reported material weakness, the company is taking steps to address the issue, and the change in auditors was not due to disagreements.

Positives

• The change in accounting firms was not due to disagreements over accounting principles or practices.
• The company has a plan to remediate the previously reported material weakness in internal control over financial reporting.
• Sadler agrees with the statements made by GRI Bio regarding their dismissal.

Negatives

• The company previously reported a material weakness in its internal control over financial reporting related to the accounting of pre-pricing of certain warrants.

Risks

• The company's ability to maintain effective internal controls over financial reporting is crucial for accurate financial reporting and compliance.
• Failure to fully remediate the previously identified material weakness could lead to future financial reporting issues.

Industry Context

Changes in auditors are not uncommon, but it's important to ensure a smooth transition and maintain investor confidence. Companies often switch auditors for various reasons, including cost, expertise, or to avoid potential conflicts of interest. The disclosure of no disagreements is a positive sign.

Comparison to Industry Standards

• Auditor changes are a regular occurrence in the industry.
• Companies like Pfizer, Apple, and Microsoft have all changed auditors at some point.
• The key is to ensure a smooth transition and maintain investor confidence, which GRI Bio seems to be doing by disclosing no disagreements with the previous auditor.

Stakeholder Impact

• Shareholders should be aware of the change in auditors and the previously reported material weakness.
• The company's management is responsible for ensuring a smooth transition and maintaining effective internal controls.

Key Dates

Keywords

accounting firm, WithumSmith+Brown, Sadler Gibb & Associates, independent auditor, internal control, GRI Bio, auditor